A recent article in the Philadelphia Inquirer described a female psychiatrist whose license was revoked after the state medical board found that she had a years-long sexual relationship with a male patient she began treating at seventeen, while continuing to prescribe him a rotating regimen of up to twelve medications, including stimulants and benzodiazepines. The board also found that she prescribed medications to his mother and father, even though neither was her patient. According to the patient, the psychiatrist became deeply enmeshed in his family, attending dinners and events, including his mother’s wedding in California.

The psychiatrist is appealing the decision. Although most documented cases involve male clinicians and female patients, this case reverses the familiar gender pattern without altering the underlying hierarchy of clinical power. More importantly, it illustrates why sexual involvement with a current patient should not be softened by the language of a “dual relationship.” It is exploitation sustained by clinical authority.

Professional codes and licensing bodies worldwide treat sexual conduct with current patients as serious misconduct due to the inherent power imbalance: The clinician controls diagnosis, medications, and access to care, while the patient is vulnerable and dependent, often with a history of trauma. Psychiatry presents a uniquely asymmetric context. Psychiatrists are privy to patients’ most intimate fears, past traumas, and dependency needs. Under these conditions, engaging in a sexual relationship is both legally and ethically indefensible.

When the clinician continues to “treat” the patient by writing notes, adjusting medications, and scheduling visits, while also serving as a lover, benefactor, or intimate partner, every clinical decision is tainted by personal motives. The patient cannot meaningfully seek a second opinion or refuse care without jeopardizing the relationship.

Psychotropic prescribing as a tool of control

Sedatives, hypnotics, and anxiolytics, especially benzodiazepines, carry recognized risks of tolerance, dependence, withdrawal, and misuse. Medicolegal analyses emphasize that malpractice claims frequently arise from failure to prescribe appropriate doses, negligent prescribing, inadequate monitoring for adverse effects, and prescribing addictive drugs to vulnerable patients.

When a psychiatrist who is sexually involved with a patient also controls access to stimulants and benzodiazepines, the boundary breach constitutes pharmacologic captivity. The clinician can, in effect, reward compliance or punish autonomy through dose escalations, abrupt changes, or threatened discontinuation, precisely the conduct malpractice guidance warns against. Documentation may erode, careful risk-benefit discussion may disappear, and the patient’s growing physiologic dependence may be misrepresented as “worsening illness.”

Boundaries, gifts, and role confusion

Ethical psychiatric practice relies on clearly defined roles: The psychiatrist is not a friend, employer, or romantic partner. Formal guidance on history-taking and mental status examination emphasizes informed consent, competence, and the need to protect vulnerable populations through mandatory reporting and the duty to protect or warn when there is a risk of serious harm.

When clinicians give expensive gifts, hire patients, or become entangled with families outside treatment, they erode these boundaries and create powerful conflicts of interest. In paraphilic disorders, experts note that when there is significant potential for harm to others, long-term monitoring and clear strategies to protect potential victims are essential. Although that literature concerns patients as potential perpetrators, the same logic applies to clinicians whose behavior places patients at risk: The system must shift from trust in individual “good character” to structured oversight, clear rules, and enforceable consequences.

Why current sanctioning often fails patients

Analyses of sexual misconduct adjudication have criticized lenient sanctions and highly subjective mitigating factors (such as good-character references and time elapsed) that overlook patterns of grooming, coercion, and power abuse. The authors argue that “clumsy” boundary slips may respond to remediation, but deliberate, coercive, exploitative behaviors should be incompatible with continued practice.

In psychiatry, where treatment is as much relational as pharmacologic, sexual exploitation should be viewed not as a private moral failing but as a direct attack on patient safety. The erosion of trust extends beyond the victim; communities watching such cases understandably question whether psychiatrists can be trusted with access to their histories, their children, and controlled substances.

Restoring safeguards: what clinicians and institutions must do

To reduce the risk of such devastation, non-negotiable boundaries must be reinforced through training and supervision. Ethics reviews in psychiatry emphasize that codes alone are insufficient; ongoing reflection, case discussion, and supervision are required to navigate complex power dynamics and emerging challenges, including digital psychiatry, social media, and novel interventional treatments (e.g., ketamine therapy).

Oversight of controlled substance prescribing should be tightened. Clear documentation of diagnosis, rationale, dosage, and monitoring for sedatives, hypnotics, and anxiolytics (along with limits on phone refills and cross-prescribing) is essential for medicolegal risk management.

Reporting should be made safer and more effective. Just as mandatory reporting of child and elder abuse and the “duty to protect” aim to prevent future harm, institutions must establish confidential, non-retaliatory pathways for staff and patients to raise concerns about sexual misconduct and prescribing abuses, along with transparent, proportionate sanctions.

Center the patient narrative. Contemporary work on clinician-written essays cautions that when we publish about patients, consent, privacy, and power must be rigorously examined, not assumed. That same discipline, attending to how our positions of narrative authority can harm, should guide our thinking about boundaries in the consulting room.

Ultimately, the lesson from this case is stark: Once a psychiatrist crosses the sexual boundary with a patient, every subsequent prescription, diagnosis, and treatment decision is ethically suspect. The profession’s response must make it clear that such conduct is incompatible with the privilege of practicing medicine.

Arthur Lazarus is a physician-author whose work spans narrative medicine, physician leadership, artificial intelligence, health care ethics, medical culture, and fiction. He has published more than 500 articles and essays across scientific journals, professional publications, and online platforms.

He is the author of numerous books on narrative medicine, AI in medicine, career development, and the changing moral landscape of health care, as well as fictional series including Rounds Never End, Sick and Systemic, and Real Medicine, Unreal Stories. His writing explores the forces reshaping modern medicine while preserving a central commitment to story, meaning, judgment, and the human relationship at the heart of care.

He shares updates on LinkedIn.